tiprankstipranks
Trending News
More News >
Diatreme Resources Limited (AU:DRX)
ASX:DRX
Australian Market
Advertisement

Diatreme Resources Limited (DRX) AI Stock Analysis

Compare
2 Followers

Top Page

AU:DRX

Diatreme Resources Limited

(Sydney:DRX)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 4o)
Rating:46Neutral
Price Target:
AU$0.02
▼(-5.00% Downside)
The overall stock score is primarily influenced by financial performance challenges, particularly in profitability and cash flow management. Technical analysis indicates a lack of momentum, and the absence of valuation metrics further limits the stock's attractiveness.
Positive Factors
Strong Balance Sheet
A strong balance sheet with low leverage provides financial stability and flexibility, allowing the company to invest in growth opportunities and withstand economic downturns.
Revenue Growth
The significant increase in revenue indicates potential market demand and successful project execution, which could lead to improved financial performance if sustained.
Strategic Partnerships
Strategic partnerships enhance operational capabilities and provide financial support, which can drive project development and expand market reach over the long term.
Negative Factors
Profitability Challenges
Persistent profitability issues indicate operational inefficiencies, which could hinder long-term growth and investor confidence if not addressed.
Negative Cash Flow
Negative cash flow suggests difficulties in generating sufficient internal funds to support operations, potentially leading to increased reliance on external financing.
Inconsistent Return on Equity
Inconsistent returns on equity may reflect volatility in earnings and operational performance, impacting investor returns and the company's ability to attract capital.

Diatreme Resources Limited (DRX) vs. iShares MSCI Australia ETF (EWA)

Diatreme Resources Limited Business Overview & Revenue Model

Company DescriptionDiatreme Resources Limited engages in the exploration of heavy mineral sands, copper, gold, and base metals in Australia. The company's flagship property is the Galalar Silica Sand project located in North Queensland. Diatreme Resources Limited was incorporated in 1993 and is based in Coorparoo, Australia.
How the Company Makes MoneyDiatreme Resources Limited generates revenue primarily through the exploration and potential development of its mineral projects, particularly in silica and rare earth elements. The company's revenue model is based on the sale of extracted mineral products once the projects reach production stage. Key revenue streams include the sale of silica products to industries such as glass manufacturing, construction, and other industrial applications. The company may also engage in partnerships or joint ventures with other mining firms to enhance its exploration capabilities and share development costs. Additionally, Diatreme could benefit from securing off-take agreements with buyers, ensuring a steady demand for its products once production commences.

Diatreme Resources Limited Financial Statement Overview

Summary
Diatreme Resources Limited shows revenue growth but struggles with profitability, as evidenced by negative EBIT and EBITDA margins. The balance sheet is strong with low leverage, but cash flow issues persist, with negative operating and free cash flows.
Income Statement
45
Neutral
Diatreme Resources Limited has demonstrated volatile revenue growth, with a recent increase to $886,464 from $468,506 in 2023, indicating a significant positive trend. However, the company has consistently reported negative EBIT and EBITDA margins, reflecting operational challenges. The net profit margin has also been negative for most years, suggesting ongoing profitability issues.
Balance Sheet
60
Neutral
The company maintains a strong equity base with a high equity ratio due to substantial stockholders' equity compared to total assets. The debt-to-equity ratio is relatively low, indicating conservative leverage. However, the return on equity has been inconsistent due to fluctuating net income, posing potential concerns regarding equity efficiency.
Cash Flow
40
Negative
Cash flow analysis reveals negative operating cash flow and free cash flow, indicating cash generation challenges. The free cash flow to net income ratio is unfavorable, highlighting inefficiencies. Nevertheless, the company has managed to secure financing to support its operations, though this may not be sustainable long-term.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.00M886.46K468.51K110.14K23.94K21.28K
Gross Profit1.00M886.46K254.29K-61.14K-77.02K-50.22K
EBITDA-3.76M-4.61M10.70M-2.94M-1.94M-795.89K
Net Income45.75K-439.53K10.37M4.98M-2.15M-1.04M
Balance Sheet
Total Assets94.61M95.45M66.53M55.33M33.14M25.62M
Cash, Cash Equivalents and Short-Term Investments3.82M5.19M10.77M13.64M6.50M5.79M
Total Debt1.17M1.20M1.75M1.54M1.61M1.64M
Total Liabilities2.33M2.51M2.96M2.59M2.37M2.40M
Stockholders Equity92.27M92.94M63.57M52.75M30.76M23.22M
Cash Flow
Free Cash Flow-5.35M-7.71M-2.80M-9.57M-8.70M-4.24M
Operating Cash Flow-3.55M-6.00M-2.32M-2.51M-2.15M-1.14M
Investing Cash Flow-1.80M1.06M-462.49K-6.95M-6.57M-2.33M
Financing Cash Flow-139.71K-643.79K-86.47K16.60M9.43M6.77M

Diatreme Resources Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.02
Price Trends
50DMA
0.02
Negative
100DMA
0.02
Negative
200DMA
0.02
Negative
Market Momentum
MACD
>-0.01
Neutral
RSI
100.00
Negative
STOCH
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DRX, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Neutral momentum. The RSI at 100.00 is Negative, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:DRX.

Diatreme Resources Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
55
Neutral
AU$162.29M-9.21-21.39%-280.00%
53
Neutral
AU$150.13M-2.48-84.61%149.43%1.20%
46
Neutral
AU$95.16M-0.27%-100.00%
43
Neutral
AU$234.54M-6.46-12.73%2.00%8.82%
37
Underperform
AU$66.01M-27.27-9.27%35.29%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:DRX
Diatreme Resources Limited
0.02
>-0.01
-17.39%
AU:A1G
African Gold Ltd.
0.53
0.48
950.00%
AU:EQR
EQ Resources Limited
0.07
0.01
27.45%
AU:ASM
Australian Strategic Materials Ltd
0.63
0.16
35.48%
AU:FHE
Frontier Energy Limited
0.28
0.15
111.54%
AU:ESR
Estrella Resources Limited
0.03
<0.01
50.00%

Diatreme Resources Limited Corporate Events

Diatreme Resources Announces Director’s Share Disposal
Oct 31, 2025

Diatreme Resources Limited announced a change in the director’s interest, specifically involving the disposal of 2,819,640 ordinary shares held indirectly by the director through a family member. This transaction, valued at $53,573, reflects a shift in the director’s investment position but does not alter the director’s holdings of unquoted options, which remain unchanged. The announcement may influence stakeholders’ perceptions of the company’s internal governance and director confidence.

Diatreme Resources Announces Shareholder Priority Offer in Moonlight IPO
Oct 29, 2025

Diatreme Resources Limited announced a corrected header for their shareholders’ priority offer in the Moonlight Resources IPO Prospectus. The offer, fully underwritten at $3.0 million, allows DRX shareholders to purchase Moonlight shares at $0.20 each, with an additional free option for every two shares acquired. This move follows Diatreme’s agreement to sell its shares in Chalcophile Resources Pty Ltd and PGE Minerals Pty Limited to Moonlight, receiving 16,250,000 Moonlight shares and $250,000 in cash. This transaction is expected to enhance Diatreme’s financial position and provide its shareholders with strategic investment opportunities.

Diatreme Sells Clermont Project to Focus on Silica Assets
Oct 29, 2025

Diatreme Resources Ltd has entered into a Share Sale Agreement with Moonlight Resources Limited to sell all outstanding shares in its subsidiaries, Chalcophile Resources Pty Ltd and PGE Minerals Pty Limited, which own the Clermont Project. As part of the transaction, Diatreme will receive 16,250,000 ordinary shares in Moonlight valued at $3,250,000 and a cash payment of A$250,000. Additionally, Diatreme shareholders are offered a priority share offer in Moonlight’s IPO, with incentives for participation. This move allows Diatreme to focus on its core silica assets while retaining an interest in the future development of the Clermont Project.

Lithium Plus Expands Gold Exposure Through Moonlight Resources Acquisition
Oct 29, 2025

Lithium Plus Minerals Ltd, a company focused on advancing its lithium portfolio and the Lei Development Project, announced that its 33.5% owned entity, Moonlight Resources Limited, has entered into a Share Sale Agreement with Diatreme Resources Ltd to acquire Chalcophile Resources Pty Ltd and PGE Minerals Pty Limited, which own the Clermont Gold Project. This acquisition provides Lithium Plus shareholders with exposure to gold assets while maintaining the company’s focus on lithium. Moonlight is offering a fully underwritten Priority Offer to Lithium Plus shareholders, allowing them to purchase shares at a discounted price with additional options, enhancing shareholder value and positioning Moonlight for future growth.

Diatreme Resources Advances Silica Project Amid Financial Improvements
Oct 28, 2025

Diatreme Resources Limited announced significant progress in its Northern Silica Project, receiving Major Project Status and advancing its Environmental Impact Statement to the final approval stages. The company reported a reduced net loss for the half year and secured a government tax rebate for its Cyclone Zircon Project. Diatreme maintains a strong cash position, with a total of $10.71 million, and continues to engage with investors through conferences and presentations.

Diatreme Resources Reports Enhanced Mineral Recoveries at Cyclone Project
Oct 23, 2025

Diatreme Resources Limited announced significant advancements in metallurgical testwork on its Cyclone project, showing improved recoveries of heavy minerals, zirconium dioxide, and titanium dioxide. The testwork, conducted by Mineral Technologies, aims to enhance mineral recoveries and optimize processing, potentially increasing shareholder value. The results, expected by November 2025, will inform the design of an improved processing flowsheet, with samples provided to potential customers for evaluation.

Diatreme Resources Secures R&D Tax Incentive Rebate for Cyclone Zircon Project
Oct 9, 2025

Diatreme Resources Limited has received a $226,894 R&D Tax Incentive Rebate from the Australian Government for its Cyclone Zircon Project, aimed at developing new processes for extracting high-purity critical mineral products. This funding will support further advances in Diatreme’s critical minerals projects, including the Cyclone and Northern Silica projects, which are aligned with Australia’s clean energy transition and regional economic development. The rebate underscores the government’s commitment to R&D and Diatreme’s role in advancing mineral and silica sands projects, benefiting stakeholders and supporting the government’s critical minerals strategy.

Diatreme Resources Director Increases Shareholding
Sep 18, 2025

Diatreme Resources Limited announced a change in the director’s interest, with Brian Joseph Flannery acquiring 256,004 ordinary shares through an on-market trade. This change increases his total shareholding to 1,117,253,701 ordinary shares, reflecting a strategic move that could influence the company’s market perception and stakeholder confidence.

Diatreme Resources Director Increases Shareholding
Sep 10, 2025

Diatreme Resources Limited has announced a change in the director’s interest notice, with Brian Joseph Flannery acquiring an additional 671,344 ordinary shares through an on-market trade. This acquisition increases his total holding to 1,116,997,697 ordinary shares, reflecting a strategic move that could impact the company’s market positioning and stakeholder interests.

Diatreme Resources Confirms High-Purity Silica Sand for Solar Industry
Sep 9, 2025

Diatreme Resources Limited has announced successful results from bulk metallurgical testwork on its Northern Silica Project, confirming the production of high-purity, low-iron silica sand suitable for photovoltaic glass. The testwork achieved high product yields with low impurities and validated the scalability of the process, supporting the project’s progression to final plant engineering and commercial agreements. This development positions the company as a potential long-term supplier in the growing solar energy market.

Diatreme Resources Director Increases Shareholding
Sep 5, 2025

Diatreme Resources Limited has announced a change in the director’s interest, with Brian Joseph Flannery acquiring an additional 24,124 ordinary shares through an on-market trade. This change reflects a minor increase in his indirect shareholding, which is held through HSBC Custody Nominees (Australia) Ltd on behalf of Ilwella Pty Ltd, a company he controls. The acquisition may indicate confidence in the company’s future prospects, potentially influencing stakeholder perceptions and market positioning.

Lithium Plus’s Moonlight Resources Acquires Clermont Gold Project
Aug 28, 2025

Lithium Plus Minerals Ltd, through its 44.7% owned entity Moonlight Resources Limited, has announced the acquisition of the Clermont Gold Project in Queensland from Diatreme Resources Ltd. This acquisition aims to establish Moonlight as a focused gold and critical minerals explorer, with plans to list on the ASX. The acquisition will provide Moonlight with a portfolio of drill-ready targets and existing rare earth and uranium opportunities. The transaction involves Moonlight issuing A$3.25 million in shares and A$250,000 in cash to Diatreme, contingent on Moonlight’s ASX listing. The move is expected to provide Lithium Plus shareholders with exposure to gold exploration while allowing the company to focus on its lithium projects.

Diatreme Resources Limited Releases Interim Financial Report for H1 2025
Aug 27, 2025

Diatreme Resources Limited has released its interim financial report for the half-year ended 30 June 2025. The report, prepared in compliance with AASB 134 and the Corporations Act 2001, provides a general overview of the company’s financial performance and position, indicating the necessity to be read alongside the annual report for complete context. This release is crucial for stakeholders to assess the company’s financial health and strategic direction during the interim period.

Diatreme Resources Secures Project Status and Key Tenure Renewals for Silica Sand Projects
Aug 25, 2025

Diatreme Resources Limited has been granted Project Status by the Queensland Government for its five exploration tenement areas in the Cape Flattery and Cape Bedford region, marking a significant milestone in its silica sand projects. This status enhances the company’s ability to streamline project development, coordinate resource and environmental assessments, and engage with stakeholders effectively, positioning Diatreme for long-term growth and development in the silica sand industry. Additionally, the company secured five-year renewals for two key exploration tenements, reinforcing its strategic position and regulatory confidence in its development approach.

Diatreme Resources Expands Exploration Targets at Northern Silica Project
Aug 22, 2025

Diatreme Resources Ltd has updated its exploration targets for the Casuarina East and West systems within its Northern Silica Project, highlighting significant potential for resource expansion. These targets, located near existing operations at Cape Flattery, could substantially increase Diatreme’s resource footprint, with estimated target tonnage ranging from 115 to 275 million tonnes. The company is progressing with exploration approvals and planning to define what could be a world-class silica sand resource, enhancing its strategic position in the silica industry.

Diatreme Resources Identifies New Exploration Targets at Northern Silica Project
Aug 18, 2025

Diatreme Resources Ltd has identified two new exploration targets, Casuarina East and Casuarina West, within its Northern Silica Project in Far North Queensland. These targets, adjacent to the existing Cape Flattery Silica Mines, show potential for significant resource expansion with estimated tonnage ranging from 115 to 275 million tonnes. The company plans to proceed with drilling to define these resources further, aiming to enhance its regional resource footprint and support future mine development.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 05, 2025